1. Academic Validation
  2. Circ-0001283 Aggravates Cardiac Hypertrophy by Targeting Myosin Light Chain 3 Protein

Circ-0001283 Aggravates Cardiac Hypertrophy by Targeting Myosin Light Chain 3 Protein

  • Research (Wash D C). 2025 Feb 25:8:0626. doi: 10.34133/research.0626.
Wenjing Wang 1 Lili Chen 2 Yiheng Zhao 3 Shuchen Zhang 3 Xiang Zhou 3
Affiliations

Affiliations

  • 1 Intensive Care Unit, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • 2 Central Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • 3 Department of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Abstract

Circular RNAs (circRNAs) are differentially expressed in cardiac hypertrophy; however, the exact function and mechanisms during hypertrophy development are still unknown. Here, we explored the role of a newly discovered circRNA in the pathogenesis of myocardial hypertrophy. It was found that circ-0001283 promoted the progression of cardiac hypertrophy by interacting with Myosin light chain 3 (MYL3) to inhibit the protein ubiquitination and enhance its protein expression, not by the competitive endogenous RNA mechanism. Further investigation demonstrated that the reduced hypertrophy induced by circ-0001283 knockdown was counteracted by overexpression of MYL3. Mechanistically, MYL3 facilitated myocardial hypertrophy by inducing Autophagy in cells via PI3K/Akt/mTOR and ERK signaling pathways. In summary, circ-0001283 can bind directly to MYL3 and up-regulate its expression, thereby promoting Autophagy to accelerate cardiac hypertrophy. Circ-0001283 may serve as a potential therapeutic target for cardiac hypertrophy.

Figures
Products